Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-26

Clinical Trial Update: Exosomal MicroRNA Expression in Children With Autism Spectrum Disorder

View source ↗

Summary

The clinical trial evaluating exosomal microRNA expression in children with autism spectrum disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: State University of New York - Upstate Medical University | Conditions: Autism Spectrum Disorder | Status: COMPLETED